• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Turnstone Biologics Corp. - Common Stock (NQ: TSBX )

    0.6642 -0.0018 (-0.27%)
    Streaming Delayed Price Updated: 10:52 AM EDT, Sep 10, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Turnstone Biologics Corp. - Common Stock

    < Previous 1 2 Next >
    Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue
    Via Benzinga
    Exposures Fossil Fuels
    Nasdaq Jumps Over 2%; Walmart Earnings Top Views
    Via Benzinga
    Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
    Turnstone Biologics stock drops after Phase 1 STARLING trial data reveals mixed results for TIDAL-01 in metastatic colorectal cancer, with a 25% response rate. 
    Via Benzinga
    Dow Surges Over 500 Points; US Retail Sales Rise In July
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Turnstone Biologics (TSBX) Stock Down 38% Today?
    Turnstone Biologics stock is down on Thursday as TSBX investors react to the company missing estimates for Q2. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today! 
    Via InvestorPlace
    Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024
    TSBX stock results show that Turnstone Biologics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024
    TSBX stock results show that Turnstone Biologics missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics Appoints William Waddill to its Board of Directors
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023
    TSBX stock results show that Turnstone Biologics beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Turnstone Biologics to Participate in Upcoming Investor Conferences
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
    Internationally recognized thought leader with extensive experience in innovative immunotherapies for solid tumors will help guide Turnstone’s continued advancement of its Selected TIL therapies 
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.